PTCT
PTC Therapeutics Inc

4,285
Mkt Cap
$6.06B
Volume
941,299.00
52W High
$87.50
52W Low
$35.95
PE Ratio
8.84
PTCT Fundamentals
Price
$75.64
Prev Close
$75.44
Open
$75.83
50D MA
$72.06
Beta
1.17
Avg. Volume
2.29M
EPS (Annual)
-$4.73
P/B
-38.82
Rev/Employee
$859,190.63
Loading...
Loading...
News
all
press releases
Armistice Capital LLC Has $231.28 Million Position in PTC Therapeutics, Inc. $PTCT
Armistice Capital LLC lessened its holdings in PTC Therapeutics, Inc. (NASDAQ:PTCT - Free Report) by 12.9% during the second quarter, according to its most recent 13F filing with the Securities...
MarketBeat·23h ago
News Placeholder
More News
News Placeholder
Marshall Wace LLP Reduces Stake in PTC Therapeutics, Inc. $PTCT
Marshall Wace LLP cut its stake in shares of PTC Therapeutics, Inc. (NASDAQ:PTCT - Free Report) by 27.4% during the second quarter, according to the company in its most recent Form 13F filing with...
MarketBeat·4d ago
News Placeholder
PTC Therapeutics, Inc. $PTCT Stock Position Raised by Hood River Capital Management LLC
Hood River Capital Management LLC boosted its holdings in PTC Therapeutics, Inc. (NASDAQ:PTCT - Free Report) by 654.4% during the second quarter, according to its most recent Form 13F filing with the...
MarketBeat·5d ago
News Placeholder
Emma Reeve Sells 733 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock
PTC Therapeutics, Inc. (NASDAQ:PTCT - Get Free Report) Director Emma Reeve sold 733 shares of the business's stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average...
MarketBeat·6d ago
News Placeholder
PTC Therapeutics (NASDAQ:PTCT) Director Emma Reeve Sells 733 Shares
PTC Therapeutics, Inc. (NASDAQ:PTCT - Get Free Report) Director Emma Reeve sold 733 shares of the company's stock in a transaction dated Wednesday, December 3rd. The stock was sold at an average...
MarketBeat·7d ago
News Placeholder
PTC Therapeutics (NASDAQ:PTCT) Downgraded to Hold Rating by Wall Street Zen
Wall Street Zen cut shares of PTC Therapeutics from a "buy" rating to a "hold" rating in a research note on Saturday...
MarketBeat·7d ago
News Placeholder
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) CEO Sells $271,051.96 in Stock
PTC Therapeutics, Inc. (NASDAQ:PTCT - Get Free Report) CEO Matthew Klein sold 3,428 shares of the business's stock in a transaction dated Tuesday, December 2nd. The shares were sold at an average...
MarketBeat·8d ago
News Placeholder
PTC Therapeutics (NASDAQ:PTCT) Shares Down 5.6% - Time to Sell?
PTC Therapeutics (NASDAQ:PTCT) Shares Down 5.6% - Here's What Happened...
MarketBeat·9d ago
News Placeholder
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) CEO Sells 3,428 Shares of Stock
PTC Therapeutics, Inc. (NASDAQ:PTCT - Get Free Report) CEO Matthew Klein sold 3,428 shares of PTC Therapeutics stock in a transaction dated Tuesday, December 2nd. The shares were sold at an average...
MarketBeat·9d ago
News Placeholder
A PTC Therapeutics (PTCT) Insider Sold 10,000 Shares for $795,000
Key PointsEmma Reeve recently exercised some PTC Therapeutics stock options and sold the shares immediately...
Nasdaq News: Markets·14d ago

Latest PTCT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.